News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
706,239 Results
Type
Article (41781)
Company Profile (257)
Press Release (664201)
Multimedia
Podcasts (50)
Webinars (12)
Section
Business (205833)
Career Advice (2143)
Deals (35618)
Drug Delivery (96)
Drug Development (81391)
Employer Resources (174)
FDA (16265)
Job Trends (15034)
News (347725)
Policy (32814)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2661)
Accelerated approval (5)
Adcomms (22)
Allergies (84)
Alliances (50031)
ALS (91)
Alzheimer's disease (1386)
Antibody-drug conjugate (ADC) (124)
Approvals (16268)
Artificial intelligence (260)
Autoimmune disease (22)
Automation (16)
Bankruptcy (363)
Best Places to Work (11720)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (180)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (280)
Cancer (2261)
Cardiovascular disease (175)
Career advice (1793)
Career pathing (31)
CAR-T (149)
Cell therapy (419)
Cervical cancer (20)
Clinical research (66166)
Collaboration (841)
Compensation (524)
Complete response letters (19)
COVID-19 (2628)
CRISPR (39)
C-suite (240)
Cystic fibrosis (100)
Data (2194)
Decentralized trials (2)
Denatured (19)
Depression (43)
Diabetes (268)
Diagnostics (6496)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (122)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86764)
Editorial (36)
Employer branding (22)
Employer resources (149)
Events (113250)
Executive appointments (722)
FDA (17514)
Featured Employer (49)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (751)
Gene editing (104)
Generative AI (21)
Gene therapy (301)
GLP-1 (716)
Government (4456)
Grass and pollen (4)
Guidances (54)
Healthcare (18992)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (116)
Indications (29)
Infectious disease (2772)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (96)
Interviews (338)
IPO (16553)
IRA (40)
Job creations (3724)
Job search strategy (1526)
Kidney cancer (10)
Labor market (38)
Layoffs (472)
Leadership (20)
Legal (7960)
Liver cancer (75)
Lung cancer (322)
Lymphoma (152)
Machine learning (7)
Management (59)
Manufacturing (303)
MASH (66)
Medical device (13478)
Medtech (13483)
Mergers & acquisitions (19608)
Metabolic disorders (681)
Multiple sclerosis (79)
NASH (16)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1924)
NextGen: Class of 2025 (6618)
Non-profit (4562)
Northern California (2657)
Now hiring (39)
Obesity (364)
Opinion (215)
Ovarian cancer (76)
Pain (85)
Pancreatic cancer (83)
Parkinson's disease (150)
Partnered (21)
Patents (231)
Patient recruitment (108)
Peanut (46)
People (57809)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20617)
Phase II (29139)
Phase III (21706)
Pipeline (1176)
Policy (137)
Postmarket research (2577)
Preclinical (8810)
Press Release (68)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (248)
Rare diseases (379)
Real estate (6072)
Recruiting (66)
Regulatory (22465)
Reports (46)
Research institute (2417)
Resumes & cover letters (359)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (68)
Series A (131)
Series B (84)
Service/supplier (13)
Sickle cell disease (52)
Southern California (2292)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (31)
Startups (3644)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (37)
The Weekly (29)
United States (23033)
Vaccines (686)
Venture capitalists (41)
Weight loss (233)
Women's health (35)
Worklife (16)
Date
Today (210)
Last 7 days (873)
Last 30 days (2710)
Last 365 days (33046)
2025 (10501)
2024 (35446)
2023 (40337)
2022 (51496)
2021 (56038)
2020 (54545)
2019 (47112)
2018 (35444)
2017 (32556)
2016 (32008)
2015 (37989)
2014 (31718)
2013 (26835)
2012 (29042)
2011 (29708)
2010 (27656)
Location
Africa (750)
Alabama (53)
Alaska (7)
Arizona (234)
Arkansas (13)
Asia (38429)
Australia (6271)
California (6089)
Canada (2012)
China (522)
Colorado (266)
Connecticut (273)
Delaware (147)
Europe (82642)
Florida (902)
Georgia (209)
Idaho (58)
Illinois (530)
India (25)
Indiana (308)
Iowa (11)
Japan (160)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (890)
Massachusetts (4556)
Michigan (216)
Minnesota (390)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (65)
New Jersey (1719)
New Mexico (29)
New York (1741)
North Carolina (966)
North Dakota (8)
Northern California (2657)
Ohio (208)
Oklahoma (14)
Oregon (34)
Pennsylvania (1368)
Puerto Rico (12)
Rhode Island (33)
South America (1128)
South Carolina (22)
South Dakota (1)
Southern California (2292)
Tennessee (101)
Texas (903)
Utah (183)
Virginia (145)
Washington D.C. (61)
Washington State (554)
West Virginia (3)
Wisconsin (54)
706,239 Results for "akili interactive labs inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Virtual Therapeutics Announces Results of Tender Offer to Acquire Akili Interactive
July 2, 2024
·
6 min read
Business
Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan
Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan.
February 26, 2024
·
7 min read
Drug Development
PureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in Japan
PureTech Health plc, a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, noted that its Founded Entity Akili, Inc. announced that its Japanese partner Shionogi & Co. Ltd has submitted Akili’s digital therapeutic SDT-001 for marketing approval with the Ministry of Health, Labor, and Welfare.
February 27, 2024
·
10 min read
Business
Akili Reports First Quarter 2024 Financial Results and Provides Business Update
Akili, Inc., a leading digital medicine company, reported its financial results for the quarter ended March 31, 2024 and provided an update on business progress.
May 14, 2024
·
13 min read
Business
Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results
Akili, Inc. including an amendment to its strategic distribution agreement with Shionogi & Co., Ltd. (“Shionogi”), a leading global pharmaceutical company.
April 30, 2024
·
9 min read
Genetown
Akili Announces FDA Authorization of EndeavorOTC, the First FDA Clearance of a Digital Treatment for Adults with ADHD Through a Video Game
Akili, Inc. (Nasdaq: AKLI), a leading digital therapeutics company, today announced U.S. Food and Drug Administration (FDA) clearance of EndeavorOTCⓇ (AKL-T01) as an over-the-counter treatment for adults with attention-deficit/hyperactivity disorder (ADHD).
June 18, 2024
·
11 min read
Business
Akili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today reported its financial results for the quarter and full year ended December 31, 2023, and provided an update on business progress.
February 29, 2024
·
18 min read
Press Releases
Interactive Strength Inc. (Nasdaq: TRNR) Plans to Announce More Acquisition News at Conference Presentation on February 11
February 6, 2025
·
3 min read
Press Releases
ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024
April 1, 2025
·
21 min read
Press Releases
ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025
March 28, 2025
·
1 min read
1 of 70,624
Next
